5-Methoxy 2-aminoindane

N/A

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug Name5-Methoxy 2-aminoindane
Drug Alias NameMEAICMND-1005-MeO-AI
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor modulatorsSerotonin 2a (5-HT2a) receptor modulators
TargetsSerotonin 1a (5-HT1a) receptorSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsCocaine-Related DisordersAlcoholismAlcohol-Related Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIsrael
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesClearmind Medicine Inc
China Registration ClassN/A

Develop Information

Active CompaniesBIRAD-Research and Development Co LtdClearmind Medicine IncPolyrizon Ltd
Inactive CompaniesSciSparc Ltd
Active IndicationsAlcoholismAlcohol-Related Disorders
Inactive IndicationsCocaine-Related Disorders

Other Information

ATC CodeN/A
Related LinksN/A